Home > Result Summaries: Compounds > GSK2256098 Result Summaries: GSK2256098 GSKStudy ID Phase Title Summary (Download) 113517 phase 1 A Phase I Open-Label Dose Escalation Study of the Focal Adhesion Kinase Inhibitor, GSK2256098, in Subjects with Solid Tumors (0 citation(s)) 113581 phase 1 A Phase I, Randomized, Single-Blind, Placebo-Controlled Dose-Escalation Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Food Effect Following Single Oral Doses of the Focal Adhesion Kinase Inhibitor, GSK2256098, in Healthy Subjects (0 citation(s))
